JP6803067B2 - Skull joint member - Google Patents
Skull joint member Download PDFInfo
- Publication number
- JP6803067B2 JP6803067B2 JP2016228643A JP2016228643A JP6803067B2 JP 6803067 B2 JP6803067 B2 JP 6803067B2 JP 2016228643 A JP2016228643 A JP 2016228643A JP 2016228643 A JP2016228643 A JP 2016228643A JP 6803067 B2 JP6803067 B2 JP 6803067B2
- Authority
- JP
- Japan
- Prior art keywords
- skull
- bone
- bmp
- communication hole
- firing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Description
本発明は、β−リン酸三カルシウムからなる頭蓋骨接合部材及びその製造方法に関する。 The present invention relates to a skull joining member made of β-tricalcium phosphate and a method for producing the same.
骨は、生体の様々な部位を支持及び保護する上で非常に重要な役割を果たしている。特に、生体にとって重要な脳は頭蓋骨に覆われることにより保護されている。外傷や腫瘍切除後などにより頭蓋骨が欠損した場合は、脳に対する保護のためにも、早期に再建することが求められている。また、皮膚の陥没等の外見上の変形が起こってしまうため、審美上の理由からも、早期の再建が望まれている。 Bone plays a very important role in supporting and protecting various parts of the living body. In particular, the brain, which is important for living organisms, is protected by being covered with a skull. When the skull is lost due to trauma or tumor resection, it is required to be reconstructed at an early stage to protect the brain. In addition, since appearance deformation such as skin depression occurs, early reconstruction is desired for aesthetic reasons.
頭蓋骨の再建方法としては、自家骨(自分の骨)、樹脂、金属、及びバイオセラミックスなどにより欠損部の補填、再建を行う方法が挙げられる。自家骨を用いた再建方法では、頭蓋骨、腸骨及び肋骨等の一部を採取して、欠損部に補填し、頭蓋骨を再建する。患者自身の組織を用いるため、人工骨と比較すると補填後の安定性に優れる。一方で、採取部位に骨欠損による変形や傷跡が残り、痛みを伴うため、患者への負担も大きいとされている。 Examples of the method for reconstructing the skull include a method of filling and reconstructing a defect with autologous bone (own bone), resin, metal, bioceramics and the like. In the reconstruction method using autologous bone, a part of the skull, ilium, ribs, etc. is collected, filled in the defect, and the skull is reconstructed. Since it uses the patient's own tissue, it has excellent stability after replacement compared to artificial bone. On the other hand, it is said that the burden on the patient is heavy because deformation and scars due to bone defects remain at the collection site and are painful.
チタン等の金属は生体親和性を有し、頭蓋骨の再建に用いる際の強度面で優れているとされている。しかし、非吸収性で生体内に残存し、体内への移植後、異物反応が見られることがあるとされている。 Metals such as titanium have biocompatibility and are said to be excellent in strength when used for reconstruction of the skull. However, it is said that it is non-absorbable and remains in the living body, and a foreign body reaction may be observed after transplantation into the body.
ハイドロキシアパタイトやリン酸三カルシウム(TCP)等のバイオセラミックスを用いた再建方法では、成形体、線維状、網状及び粉体等の形態で欠損部に補填し、頭蓋骨の再建を行う。これらは生体親和性が非常に高く、体内へ移植した際に吸収性が高く、骨に置換されていくことが報告されている。また、これらの人工骨が多孔体であることが好ましいとの報告も多くなされている。 In the reconstruction method using bioceramics such as hydroxyapatite and tricalcium phosphate (TCP), the defect is filled in the form of a molded body, fibrous, reticular, powder or the like, and the skull is reconstructed. It has been reported that these have very high biocompatibility, are highly resorbable when transplanted into the body, and are replaced by bone. In addition, there are many reports that it is preferable that these artificial bones are porous.
特許文献1では、気孔率50〜90%、連通する気孔径50〜1000μmと5μm以下の気孔を有するリン酸カルシウム多孔体又は多孔質顆粒を骨欠損部に充填し、生体内吸収性有機材料等で上面を覆うことで頭蓋骨の再建を行っている。しかし、特許文献1の再建部材は粒子体または顆粒状の足場材料であるため、生体内で足場材料が流出しやすい問題があった。 In Patent Document 1, a calcium phosphate porous body or porous granules having a porosity of 50 to 90% and communicating pore diameters of 50 to 1000 μm and 5 μm or less is filled in the bone defect portion, and the upper surface is coated with an organic material that can be absorbed in vivo. The skull is being reconstructed by covering it. However, since the reconstructed member of Patent Document 1 is a scaffold material in the form of particles or granules, there is a problem that the scaffold material easily flows out in the living body.
特許文献2には、膨張性材料からなるプラグインプラントが記載されており、生体吸収性ポリカプロラクトンなどの膨張性材料からなるフィラメント層を積層した多孔質構造が示されている。特許文献2によれば、当該プラグインプラントは容易に使用することができ、さらに骨に取り付けるための手段が必要ないとされている。しかしながら、当該プラグインプラントの孔は3次元的に連通しており、インプラントの表面積が大きいために骨組織の再生に時間がかかるおそれがあり、頭蓋骨における骨組織の再生が必ずしも十分とはいえなかった。 Patent Document 2 describes a plug implant made of an expandable material, and shows a porous structure in which a filament layer made of an expandable material such as bioabsorbable polycaprolactone is laminated. According to Patent Document 2, the plug implant can be easily used and does not require any means for attaching to the bone. However, since the holes of the plug implant communicate three-dimensionally and the surface area of the implant is large, it may take time to regenerate the bone tissue, and the regeneration of the bone tissue in the skull is not always sufficient. ..
特許文献3には、構造化された多孔率を有するモネタイトの三次元マトリクスであって、三次元マトリクスの構造内に、直径が350〜650μmである垂直な円筒形のマクロ孔を有し、マクロ孔が一端から他端へ向かってマトリクスを縦方向へ貫通し、各マクロ孔は0.4〜0.6mmの距離で離れていることを特徴とする三次元マトリクスが記載されている。特許文献3によれば、これらのマトリクスは、生体適合性、再吸収、骨誘導および血管再生(revascularization)などの有利な特性を有しているので、細胞の定着(colonization)および増殖にとって最高の足場となりえるため、これらのマトリクスを組織工学及び骨再生に用いることが可能であるとされている。しかしながら、当該三次元マトリクスはモネタイトからなるため強度が十分でなく、マクロ孔の孔径やピッチに制限があった。また、当該三次元マトリクスを頭蓋骨欠損へ適用するには力学的な強度が十分ではなく、マクロ孔の配向については検討されていなかった。 Patent Document 3 describes a three-dimensional matrix of monetite having a structured porosity, which has a vertical cylindrical macropore having a diameter of 350 to 650 μm in the structure of the three-dimensional matrix. A three-dimensional matrix is described characterized in that the holes penetrate the matrix longitudinally from one end to the other and the macro holes are separated by a distance of 0.4 to 0.6 mm. According to Patent Document 3, these matrices have advantageous properties such as biocompatibility, resorption, bone induction and revascularization, and are therefore best for cell colonization and proliferation. Since it can be used as a scaffold, it is said that these matrices can be used for tissue engineering and bone regeneration. However, since the three-dimensional matrix is made of monetite, its strength is not sufficient, and the pore diameter and pitch of macropores are limited. In addition, the mechanical strength was not sufficient to apply the three-dimensional matrix to skull defects, and the orientation of macropores was not investigated.
本発明は上記課題を解決するためになされたものであり、生体親和性が良好であり、骨組織の形成に優れた頭蓋骨接合部材を提供することを目的とする。また、そのような頭蓋骨接合部材の好適な製造方法を提供する。 The present invention has been made to solve the above problems, and an object of the present invention is to provide a skull joining member having good biocompatibility and excellent formation of bone tissue. Also provided are suitable methods of manufacturing such skull joint members.
上記課題は、β−リン酸三カルシウム(以下、β−TCPとする)からなる頭蓋骨接合部材であって、部材は一面から他面まで垂直方向に連通する複数の連通孔が設けられており、連通孔の孔径が100〜1500μmであり、硬膜と骨膜とが最短距離で結ばれる仮想軸と連通孔の向きとが略平行となるように骨欠損部に部材を配置することにより頭蓋骨を再建するために用いられることを特徴とする、頭蓋骨接合部材によって解決される。 The above-mentioned problem is a skull joint member made of β-tricalcium phosphate (hereinafter referred to as β-TCP), and the member is provided with a plurality of communication holes that communicate vertically from one surface to the other. The skull is reconstructed by arranging members in the bone defect so that the hole diameter of the communication hole is 100 to 1500 μm and the virtual axis connecting the dura mater and the periosteum at the shortest distance and the direction of the communication hole are substantially parallel. It is solved by a skull joint member, which is characterized by being used to.
このとき、部材の厚みが、1〜20mmであることが好ましい。また、部材の気孔率が20〜60%であることが好ましい。 At this time, the thickness of the member is preferably 1 to 20 mm. Further, the porosity of the member is preferably 20 to 60%.
またこのとき、連通孔と連通孔との間の壁面の厚さが400μm未満であることも好ましい。また、連通孔の内部にBMPが充填されてなることも好ましい。 At this time, it is also preferable that the thickness of the wall surface between the communication holes is less than 400 μm. It is also preferable that the inside of the communication hole is filled with BMP.
上記課題は、連通孔を設けた後に、1000〜1400℃で焼成する工程を有する頭蓋骨接合部材の製造方法を提供することによっても解決される。このとき、焼成する工程の後に、BMPを0.1〜1000μg/mL含む媒体に部材を含浸させることが好適な実施態様である。 The above problem is also solved by providing a method for manufacturing a skull joining member having a step of firing at 1000 to 1400 ° C. after providing a communication hole. At this time, it is a preferable embodiment to impregnate the member with a medium containing 0.1 to 1000 μg / mL of BMP after the step of firing.
本発明の頭蓋骨接合部材は、生体親和性が良好であり、骨組織の形成に優れている。これにより、頭蓋骨欠損部を有する患者の脳の保護に有効であり、再建が難しいとされている頭蓋骨においても早期に骨再生することが可能となる。本発明の製造方法によれば、そのような頭蓋骨接合部材を容易に製造することができる。 The skull joint member of the present invention has good biocompatibility and is excellent in bone tissue formation. This is effective in protecting the brain of a patient having a skull defect, and enables early bone regeneration even in a skull that is difficult to reconstruct. According to the manufacturing method of the present invention, such a skull joint member can be easily manufactured.
以下、本発明の実施形態について説明する。 Hereinafter, embodiments of the present invention will be described.
本発明の頭蓋骨接合部材は、β−TCPからなり、前記部材は一面から他面まで垂直方向に連通する複数の連通孔が設けられており、前記連通孔の孔径が100〜1500μmであり、硬膜と骨膜とが最短距離で結ばれる仮想軸と前記連通孔の向きとが略平行となるように骨欠損部に前記部材を配置することにより頭蓋骨を再建するために用いられることを特徴とする。 The skull joint member of the present invention is made of β-TCP, and the member is provided with a plurality of communication holes that communicate vertically from one surface to the other, and the hole diameter of the communication holes is 100 to 1500 μm and is hard. It is characterized in that it is used to reconstruct the skull by arranging the member in the bone defect portion so that the virtual axis connecting the membrane and the periosteum at the shortest distance and the direction of the communication hole are substantially parallel to each other. ..
本発明では、硬膜と骨膜とが最短距離で結ばれる仮想軸と前記連通孔の向きとが略平行となるように骨欠損部に前記部材を配置することが重要である。このように配置することで、頭蓋骨板間層に対し連通孔の向きが略垂直となり、このときの連通孔を垂直連通孔ということがある。 In the present invention, it is important to arrange the member in the bone defect portion so that the virtual axis connecting the dura mater and the periosteum at the shortest distance and the direction of the communication hole are substantially parallel to each other. By arranging in this way, the direction of the communication hole becomes substantially perpendicular to the intercranial diploë, and the communication hole at this time may be referred to as a vertical communication hole.
後述する実施例と比較例の対比からもわかるように、β−TCPからなり、孔径が100〜1500μmの連通孔を複数有する頭蓋骨接合部材であっても、硬膜と骨膜とが最短距離で結ばれる仮想軸と前記連通孔の向きとが略垂直となるように骨欠損部に部材を配置した比較例1及び2では、良好な骨形成が確認されなかった。このように配置することで、頭蓋骨板間層に対し連通孔の向きが略水平となり、このときの連通孔を水平連通孔ということがある。これに対し、骨欠損部において、硬膜と骨膜とが最短距離で結ばれる仮想軸と連通孔の向きとが略平行となるように頭蓋骨接合部材を配置した実施例1及び2では、良好な骨形成が確認された。実施例1及び2の結果からわかるように、頭蓋骨における骨欠損部位では、硬膜側から骨膜側へ向かって骨形成が進むことが確認された。本発明の頭蓋骨接合部材により硬膜と骨膜とが垂直連通孔を通じて直線的に結ばれ、連通孔内へ骨芽細胞が十分に供給され、骨組織の形成に優れていることがわかる。 As can be seen from the comparison between Examples and Comparative Examples described later, even in a skull joint member made of β-TCP and having a plurality of communication holes having a pore diameter of 100 to 1500 μm, the dura mater and the periosteum are connected at the shortest distance. Good bone formation was not confirmed in Comparative Examples 1 and 2 in which the members were arranged in the bone defect portion so that the virtual axis and the direction of the communication hole were substantially perpendicular to each other. By arranging in this way, the direction of the communication hole becomes substantially horizontal with respect to the intercranial diploë, and the communication hole at this time may be referred to as a horizontal communication hole. On the other hand, in Examples 1 and 2 in which the skull joint member is arranged so that the virtual axis connecting the dura mater and the periosteum at the shortest distance and the direction of the communication hole are substantially parallel in the bone defect portion, it is good. Bone formation was confirmed. As can be seen from the results of Examples 1 and 2, it was confirmed that bone formation progressed from the dural side to the periosteal side at the bone defect site in the skull. It can be seen that the dura mater and the periosteum are linearly connected through the vertical communication hole by the skull joint member of the present invention, osteoblasts are sufficiently supplied into the communication hole, and the formation of bone tissue is excellent.
本発明の頭蓋骨接合部材は、β−TCPからなるものであるが、β−TCPを主成分とするものであればよく、一部にα−TCPを含んでいてもよい。主成分とは、通常、60質量%以上である。生体吸収性が優れるため、頭蓋骨接合部材が実質的にβ−TCPのみからなることが好ましい。 The skull joining member of the present invention is made of β-TCP, but it may be composed of β-TCP as a main component and may contain α-TCP in a part thereof. The main component is usually 60% by mass or more. It is preferable that the skull junction member is substantially composed of β-TCP only because of its excellent bioabsorbability.
本発明の連通孔の孔径は、100〜1500μmである。連通孔の孔径が100μm未満の場合、骨形成される際に、軟骨が形成されやすくなるおそれがある。連通孔の孔径は200μm以上であることが好ましい。また、連通孔の孔径が1500μmより大きい場合、骨形成がされにくく、部材を足場とした骨再建が行われないおそれがある。連通孔の孔径が1200μm以下であることが好ましく、600μm以下であることがより好ましく、450μm以下であることが更に好ましい。 The hole diameter of the communication hole of the present invention is 100 to 1500 μm. If the diameter of the communication hole is less than 100 μm, cartilage may be easily formed during bone formation. The hole diameter of the communication hole is preferably 200 μm or more. Further, when the hole diameter of the communication hole is larger than 1500 μm, bone formation is difficult and bone reconstruction using the member as a scaffold may not be performed. The pore diameter of the communication hole is preferably 1200 μm or less, more preferably 600 μm or less, and further preferably 450 μm or less.
本発明の頭蓋骨接合部材に形成される連通孔の形状は特に限定されず、円形、楕円形、三角形、四角形、六角形等が挙げられる。連通孔の形状が円でない場合、円相当径を孔径とする。 The shape of the communication hole formed in the skull joining member of the present invention is not particularly limited, and examples thereof include a circle, an ellipse, a triangle, a quadrangle, and a hexagon. If the shape of the communication hole is not a circle, the diameter equivalent to the circle is used as the hole diameter.
本発明の頭蓋骨接合部材の厚みは、頭蓋骨の厚みに合わせて適宜調整されるが、1〜20mmであることが好ましい。厚みが1mm未満の場合、頭蓋骨欠損部へ適用した際の強度が不足するおそれがある。1〜10mmであることがより好ましい。 The thickness of the skull joining member of the present invention is appropriately adjusted according to the thickness of the skull, but is preferably 1 to 20 mm. If the thickness is less than 1 mm, the strength when applied to the skull defect may be insufficient. It is more preferably 1 to 10 mm.
本発明の頭蓋骨接合部材の気孔率は、20〜60%であることが好ましい。気孔率が20%未満の場合には、連通孔に骨形成は行われるが、頭蓋骨形成部材全体に対する骨の割合が低く、生体へ吸収されるまでの時間が長くなるおそれがある。一方、気孔率が60%より大きい場合には、頭蓋骨接合部材の形状を保持することが困難となるおそれがあり、また、頭部に配置した際に、外部からの力で変形しやすくなるおそれがある。 The porosity of the skull joint member of the present invention is preferably 20 to 60%. When the porosity is less than 20%, bone formation is performed in the communication hole, but the ratio of bone to the entire skull forming member is low, and the time until absorption into the living body may be long. On the other hand, if the porosity is greater than 60%, it may be difficult to maintain the shape of the skull joint member, and when it is placed on the head, it may be easily deformed by an external force. There is.
本発明の頭蓋骨接合部材における連通孔と連通孔の間の壁面の厚さは400μm未満であることが好ましい。壁面の厚さが400μm以上である場合には、頭蓋骨形成部材全体に対する骨の割合が低く、生体へ吸収されるまでの時間が長くなるおそれがある。壁面の厚さは300μm以下であることがより好ましく、150μm以下であることが更に好ましい。壁面の厚さは、連通孔の製造の容易性から50μm以上であることが好ましい。 The thickness of the wall surface between the communication holes in the skull joining member of the present invention is preferably less than 400 μm. When the thickness of the wall surface is 400 μm or more, the ratio of bone to the entire skull forming member is low, and the time until it is absorbed into the living body may be long. The thickness of the wall surface is more preferably 300 μm or less, and further preferably 150 μm or less. The thickness of the wall surface is preferably 50 μm or more from the viewpoint of ease of manufacturing the communication hole.
本発明の頭蓋骨接合部材の連通孔の内部に、細胞外マトリクス等の充填剤が充填されていることが好ましい。細胞外マトリクスとしては、特に限定されないが、コラーゲンI、フィブロネクチン、ラミニン、マトリゲル(登録商標)などが挙げられる。充填剤中に部材を浸漬することで充填剤を連通孔の内部に充填することができ、浸漬させたものをさらに遠心分離機にかけるか、あるいは減圧脱気するなどの処理をすることが好ましい。 It is preferable that the inside of the communication hole of the skull joining member of the present invention is filled with a filler such as an extracellular matrix. The extracellular matrix is not particularly limited, and examples thereof include collagen I, fibronectin, laminin, and Matrigel (registered trademark). By immersing the member in the filler, the filler can be filled inside the communication hole, and it is preferable to further centrifuge the immersed material or perform a treatment such as degassing under reduced pressure. ..
本発明の頭蓋骨接合部材の連通孔の内部に、さらに骨形成タンパク質(Bone Morphogenetic Protein、以下、BMP)などの骨形成因子が充填されていることが好ましい。これにより、骨組織の形成がより良好となる利点を有する。利用が可能な具体的なBMPとしては特に限定されないが、たとえばBMP−2、BMP−3、BMP−4、BMP−5、BMP−6、BMP−7、BMP−9、BMP−10、BMP−11、BMP−12、BMP−13、BMP−14、BMP−15、BMP−3bなどが挙げられる。中でも、BMP−2、BMP−4、BMP−7がより好ましい。BMPの配合量が多い方が、骨形成促進効果が大きくなる。BMPの含有量としては、頭蓋骨接合部材1cm3に対し、1〜500μg含有することが好ましく、10〜200μg含有することがより好ましい。 It is preferable that the inside of the communication hole of the skull joining member of the present invention is further filled with a bone morphogenetic factor such as a bone morphogenetic protein (BMP). This has the advantage of better formation of bone tissue. The specific BMP that can be used is not particularly limited, but for example, BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, BMP-7, BMP-9, BMP-10, BMP- 11, BMP-12, BMP-13, BMP-14, BMP-15, BMP-3b and the like. Of these, BMP-2, BMP-4, and BMP-7 are more preferable. The larger the amount of BMP, the greater the effect of promoting bone formation. The BMP content is preferably 1 to 500 μg and more preferably 10 to 200 μg with respect to 1 cm 3 of the skull joining member.
本発明の頭蓋骨接合部材は、頭蓋骨の骨欠損部に適合するように、大型の多孔部材から削り出して用いたり、小型の多孔部材を適宜組み合わせて用いることができる。本発明の頭蓋骨接合部材の大きさは、頭蓋骨の骨欠損部に合わせて調整される。 The skull joint member of the present invention can be used by carving out from a large porous member so as to fit the bone defect portion of the skull, or a small porous member can be appropriately combined and used. The size of the skull joint member of the present invention is adjusted according to the bone defect portion of the skull.
本発明の頭蓋骨接合部材の製造方法は、特に限定されない。一般的に、焼成温度が高温になるとα型の結晶構造が現れる。骨接合部材として焼成する場合には、β型の結晶構造を保つことのできる最も高温での焼成が好適である。β−TCP部材に連通孔を形成した後、1000〜1400℃で焼成する工程を有する方法が好適である。1000℃未満で焼成した場合には、頭部へ配置した際に生体内で強い炎症反応が引き起こされるおそれがあり、骨形成が生じないおそれがある。焼成温度は1150℃以上であることが好ましい。また、1400℃を超える温度で焼成した場合には、頭部へ配置した際に生体内で強い炎症反応が引き起こされるおそれがあり、骨形成時の足場とされる前に分解されてしまうおそれがある。焼成温度は1300℃以下であることが好ましい。なお、連通孔の作製方法は特に限定されず、押出成形やプレス成形、射出成形あるいは機械的に穿孔する方法、若しくは少なくとも一つの貫通孔を有する棒状体を束ねる方法などが挙げられる。 The method for producing the skull joint member of the present invention is not particularly limited. Generally, when the firing temperature becomes high, an α-type crystal structure appears. When firing as an osteosynthesis member, firing at the highest temperature capable of maintaining a β-type crystal structure is preferable. A method having a step of forming a communication hole in the β-TCP member and then firing at 1000 to 1400 ° C. is preferable. When calcined at a temperature lower than 1000 ° C., a strong inflammatory reaction may be caused in the living body when placed on the head, and bone formation may not occur. The firing temperature is preferably 1150 ° C. or higher. In addition, when calcined at a temperature exceeding 1400 ° C., a strong inflammatory reaction may be caused in the living body when placed on the head, and the bone may be decomposed before being used as a scaffold for bone formation. is there. The firing temperature is preferably 1300 ° C. or lower. The method for producing the communication holes is not particularly limited, and examples thereof include extrusion molding, press molding, injection molding, mechanical drilling, and a method of bundling rod-shaped bodies having at least one through hole.
本発明の頭蓋骨接合部材の製造方法は、前記焼成する工程の後に、BMPを0.1〜1000μg/mL含む媒体に前記部材を含浸させることが好ましい。骨組織の形成がより良好となる観点から、BMPの濃度は20μg/mL以上であることがより好ましく、50μg/mL以上であることが更に好ましい。一方、コスト高となる観点から、BMPの濃度は100μg/mL以下であることがより好ましい。BMPを含む媒体としては、前述の細胞外マトリクス等を好適に用いることができる。 In the method for producing a skull joining member of the present invention, it is preferable to impregnate the member with a medium containing 0.1 to 1000 μg / mL of BMP after the firing step. From the viewpoint of better formation of bone tissue, the concentration of BMP is more preferably 20 μg / mL or more, further preferably 50 μg / mL or more. On the other hand, from the viewpoint of high cost, the concentration of BMP is more preferably 100 μg / mL or less. As the medium containing BMP, the above-mentioned extracellular matrix or the like can be preferably used.
以下、実施例を用いて本発明を更に具体的に説明する。 Hereinafter, the present invention will be described in more detail with reference to Examples.
[頭蓋骨再建試験]
実施例1
CaHPO4・2H2OパウダーとCaCO3を1:2の比率で混合したものに水を加えて、ボールミルで24時間粉砕混練してスラリーを得た。前記スラリーを乾燥させ、垂直方向に連通する直径330μmの連通孔を91個有する長さ3.95mmx幅3.95mm、厚さ2mmの長方体のTCP前駆体からなる成形体を得た。前記成形体を1200℃まで50℃h−1の速度で昇温し、その温度で1時間保持して焼成処理を行い、β−TCPからなる頭蓋骨接合部材を得た。前記頭蓋骨接合部材の連通孔と連通孔の間の壁面の厚さは約100μmであり、気孔率は49.8%であった。前記頭蓋骨接合部材をオートクレーブで殺菌処理した後、マトリゲル(登録商標)(BD Bioscience社製)の中に浸漬させて遠心分離機にかけ、頭蓋骨接合部材の連通孔内にマトリゲル(登録商標)を充填させた。
[Skull reconstruction test]
Example 1
The CaHPO 4 · 2H 2 O powder and CaCO 3 1: Water was added to a mixture 2 ratio, to obtain a 24 hours grinding kneaded to a slurry in a ball mill. The slurry was dried to obtain a molded product made of a rectangular parallelepiped TCP precursor having a length of 3.95 mm, a width of 3.95 mm, and a thickness of 2 mm having 91 communication holes having a diameter of 330 μm that communicate in the vertical direction. The molded product was heated to 1200 ° C. at a rate of 50 ° C. h- 1 and held at that temperature for 1 hour for firing treatment to obtain a skull joining member made of β-TCP. The thickness of the wall surface between the communication holes of the skull joining member was about 100 μm, and the porosity was 49.8%. After the skull joint member is sterilized by an autoclave, the skull joint member is immersed in Matrigel (registered trademark) (manufactured by BD Bioscience) and centrifuged to fill the communication hole of the skull joint member with Matrigel (registered trademark). It was.
8週齢雄性ウィスター系ラットの頭蓋骨欠損モデルを用いて検討を行った。ラットの頭部の皮膚を切開した後、頭蓋骨をダイヤモンドバーを用いて切削し、硬膜を温存して約5×5mmの骨組織欠損を左右に1つずつ作成した。頭蓋骨接合部材をオートクレーブで殺菌処理し、連通孔の向きが、硬膜と骨膜とが最短距離で結ばれる仮想軸と略平行になるように骨欠損部位に配置し、頭部皮膚を縫合した。 A skull defect model of an 8-week-old male Wistar rat was used for the study. After making an incision in the skin of the rat's head, the skull was cut with a diamond bar to preserve the dura and create one bone tissue defect of about 5 x 5 mm on each side. The skull joint member was sterilized by an autoclave, and the communication hole was placed at the bone defect site so that the direction of the communication hole was substantially parallel to the virtual axis connecting the dura mater and the periosteum at the shortest distance, and the head skin was sutured.
頭蓋骨接合部材を埋入後、3週間目にラットを安楽死させ、周囲の頭蓋骨組織と共に頭蓋骨接合部材を摘出した。摘出した組織は4%パラフォルムアルデヒドで一晩固定し、続いて10%エチレンジアミン四酢酸(EDTA)溶液にて脱灰、定法にてパラフィンブロックを作成し、ヘマトキシリン・エオジンで染色(HE染色)の後、組織学的に観察を行った。結果を図1−a、bに示す。 Rats were euthanized 3 weeks after implantation of the skull junction and the skull junction was removed along with the surrounding skull tissue. The excised tissue was fixed overnight with 4% paraformaldehyde, then decalcified with a 10% ethylenediaminetetraacetic acid (EDTA) solution, a paraffin block was prepared by a conventional method, and stained with hematoxylin and eosin (HE staining). Later, histological observation was performed. The results are shown in Figures 1-a and 1-b.
実施例2
殺菌処理後の頭蓋骨接合部材の連通孔内に80μg/mL濃度のBMP−2を混和したマトリゲル(登録商標)(BD Bioscience社製)を充填した以外は実施例1と同様にして、頭蓋骨再建試験を行った。頭骸骨接合部材全体のBMP含有量は、約1.24μgであった。結果を図1−c、dに示す。
Example 2
A skull reconstruction test was carried out in the same manner as in Example 1 except that Matrigel (registered trademark) (manufactured by BD Bioscience) mixed with BMP-2 having a concentration of 80 μg / mL was filled in the communication holes of the skull joining member after the sterilization treatment. Was done. The BMP content of the entire skull joint member was about 1.24 μg. The results are shown in FIGS. 1-c and d.
比較例1
長さ3.95mm×幅3.95mm、厚さ5mmとした以外は実施例1と同様にして長方体のTCP前駆体からなる成形体を得た。実施例1と同様にして1200℃で焼成処理した前記成形体を、幅2mmの位置で切断面が連通孔と平行になるように切断して2等分し、β−TCPからなる頭蓋骨接合部材を得た。オートクレーブで殺菌処理した前記頭蓋骨接合部材を、連通孔の向きが硬膜と骨膜とが最短距離で結ばれる仮想軸と略垂直になるように骨欠損部位に配置した以外は、実施例1と同様にして頭蓋骨再建試験を行った。このとき、連通孔は頭骸骨板間層に連通孔が連絡している状態、すなわち水平連通孔となっている。結果を図2−a、bに示す。
Comparative Example 1
A molded product made of a rectangular parallelepiped TCP precursor was obtained in the same manner as in Example 1 except that the length was 3.95 mm, the width was 3.95 mm, and the thickness was 5 mm. The molded product baked at 1200 ° C. in the same manner as in Example 1 is cut at a width of 2 mm so that the cut surface is parallel to the communication hole, divided into two equal parts, and a skull joint member made of β-TCP. Got The same as in Example 1 except that the skull joint member sterilized by the autoclave was arranged at the bone defect site so that the direction of the communication hole was substantially perpendicular to the virtual axis connecting the dura mater and the periosteum at the shortest distance. Then, a skull reconstruction test was performed. At this time, the communication hole is in a state where the communication hole is in contact with the inter-skull diploë, that is, a horizontal communication hole. The results are shown in FIGS. 2-a and 2-a and b.
比較例2
殺菌処理後の頭蓋骨接合部材の連通孔内に80μg/mL濃度のBMP−2を混和したマトリゲル(登録商標)(BD Bioscience社製)を充填した以外は比較例1と同様にして、頭蓋骨再建試験を行った。結果を図2−c、dに示す。
Comparative Example 2
Skull reconstruction test in the same manner as in Comparative Example 1 except that Matrigel (registered trademark) (manufactured by BD Bioscience) mixed with BMP-2 having a concentration of 80 μg / mL was filled in the communication hole of the skull joining member after the sterilization treatment. Was done. The results are shown in FIGS. 2-c and d.
[頭蓋骨再建における組織観察結果]
実施例1のように配置された頭蓋骨接合部材では、BMPの添加がない条件においても、骨組織の形成が認められた(図1−a、b)。骨組織は硬膜側から形成されており、連通孔内の骨膜近傍にまで骨組織の形成が認められた。連通孔内に炎症反応はほとんど認められず、孔の全ての内壁に添加するように良好な骨組織が形成されていた。
[Results of tissue observation in skull reconstruction]
In the skull joint member arranged as in Example 1, the formation of bone tissue was observed even under the condition that BMP was not added (FIGS. 1-a and 1-b). The bone tissue was formed from the dural side, and the formation of bone tissue was observed up to the vicinity of the periosteum in the connected hole. Almost no inflammatory reaction was observed in the communicating hole, and good bone tissue was formed so as to be added to all the inner walls of the hole.
実施例1のように配置され、さらにBMPが添加されている頭蓋骨接合部材(実施例2)では、実施例1よりも旺盛な骨組織の形成が認められた(図1−c、d)。骨組織は全ての連通孔で孔全体を充填するように形成されており、骨組織の形成は外側の骨膜にほぼ達していた。また、骨髄組織の形成も確認された。 In the skull joint member (Example 2) arranged as in Example 1 and further added with BMP, more vigorous formation of bone tissue was observed than in Example 1 (Fig. 1-c, d). Bone tissue was formed so as to fill the entire hole with all communication holes, and the formation of bone tissue almost reached the outer periosteum. The formation of bone marrow tissue was also confirmed.
これらに対し、比較例1のように配置された頭蓋骨接合部材では、BMPの添加がない条件においても骨組織の形成は認められたが、硬膜近傍のみであった(図2−a、b)。骨膜側の孔内には骨組織の形成が認められなかった。 On the other hand, in the skull joint members arranged as in Comparative Example 1, bone tissue formation was observed even under the condition that BMP was not added, but only in the vicinity of the dura mater (Fig. 2-a, b). ). No formation of bone tissue was observed in the hole on the periosteal side.
また、比較例1のように配置され、さらにBMPが添加されている頭蓋骨接合部材(比較例2)では、比較例1よりも骨組織の形成される量は増加したが、全ての孔に骨形成は認められなかった(図2−c、d)。 Further, in the skull joint member (Comparative Example 2) arranged as in Comparative Example 1 and further added with BMP, the amount of bone tissue formed was increased as compared with Comparative Example 1, but bone was formed in all the holes. No formation was observed (Fig. 2-c, d).
参考例1
CaHPO4・2H2OパウダーとCaCO3を1:2の比率で混合したものに水を加えて、ボールミルで24時間粉砕混練してスラリーを得た。前記スラリーを乾燥させ、直径330μmの貫通孔を91個有する長さ3.95mmx幅3.95mm、厚さ1mmの長方体のTCP前駆体からなる成形体を得た(気孔率:49.8%)。得られた前記成形体を1100℃まで50℃h−1の速度で昇温し、その温度で1時間保持して焼成処理を行った。
Reference example 1
The CaHPO 4 · 2H 2 O powder and CaCO 3 1: Water was added to a mixture 2 ratio, to obtain a 24 hours grinding kneaded to a slurry in a ball mill. The slurry was dried to obtain a molded product made of a rectangular parallelepiped TCP precursor having 91 through holes having a diameter of 330 μm, a length of 3.95 mm, a width of 3.95 mm, and a thickness of 1 mm (porosity: 49.8). %). The obtained molded product was heated to 1100 ° C. at a rate of 50 ° C. h -1 and held at that temperature for 1 hour for firing treatment.
[X線回折の測定]
前記焼成処理を行った成形体(1100TCP)について、XRD(BRUKER D8 Advance)を用いて、X線回折を測定した(X線:Cu-Kα線、出力:40KV、40mA)。スキャン角度の範囲は20°〜60°、スキャンスピードは2°min-1であった。回折パターンはJoint Committee on Powder Diffraction Standards Powder Diffraction Filesのデータベースと比較した。
[Measurement of X-ray diffraction]
X-ray diffraction was measured using XRD (BRUKER D8 Advance) on the molded product (1100TCP) subjected to the firing treatment (X-ray: Cu-Kα ray, output: 40 KV, 40 mA). The scan angle range was 20 ° to 60 ° and the scan speed was 2 ° min- 1 . Diffraction patterns were compared with the Joint Committee on Powder Diffraction Standards Powder Diffraction Files database.
[表面形態の観察]
焼成処理後の成形体に白金コーティングを行い、SEM(Philips XL30W10D)を用いて表面構造を観察した。結果を図3に示す。
[Observation of surface morphology]
The molded product after the firing treatment was coated with platinum, and the surface structure was observed using SEM (Philips XL30W10D). The results are shown in FIG.
[骨再生試験]
2匹の健康な4週齢雄性ウィスター系ラットを用いて試験を行った。外耳道に骨欠損部を設け、骨欠損部を補うように成形体(1200TCP)を埋入した。4週間後、成形体(1200TCP)をラットから取り出し、中性緩衝ホルマリン中で固定した。そのサンプルを10%EDTA溶液中で2週間浸漬し、カルシウムを除去した。引き続き、サンプルをパラフィン中に埋め込み、切片をHE染色し、組織学的に観察を行った。結果を図4に示す。
[Bone regeneration test]
The test was performed on two healthy 4-week-old male Wistar rats. A bone defect was provided in the ear canal, and a molded body (1200 TCP) was implanted to compensate for the bone defect. After 4 weeks, the molding (1200TCP) was removed from the rat and fixed in neutral buffered formalin. The sample was immersed in 10% EDTA solution for 2 weeks to remove calcium. Subsequently, the sample was embedded in paraffin, the sections were HE-stained, and histological observation was performed. The results are shown in FIG.
参考例2〜6
前記焼成処理の温度を表1に示すように変更した以外は、参考例1と同様にして焼成処理を行い、評価した。結果を表1及び図3〜5に示す。
Reference examples 2-6
The firing treatment was performed and evaluated in the same manner as in Reference Example 1 except that the temperature of the firing treatment was changed as shown in Table 1. The results are shown in Table 1 and FIGS. 3-5.
[X線回折結果]
参考例1〜6のX線回折結果より、焼成処理後の成形体の組成が焼成温度に依存することがわかった(表1)。焼成温度が1100、1150、1200℃のサンプルでは、焼成後の成形体の組成としてβ−TCPのピークのみが検出された(図5−a)。焼成温度が1250℃のサンプルでは、焼成後の成形体の組成として主にβ−TCPのピークが検出され、少しα−TCPのピークも検出された(図5−b)。焼成温度が1500℃のサンプルでは、β−TCPのピークは確認されず、α−TCPのピークのみ検出された(図5−c)。
[X-ray diffraction result]
From the X-ray diffraction results of Reference Examples 1 to 6, it was found that the composition of the molded product after the firing treatment depends on the firing temperature (Table 1). In the samples having the firing temperatures of 1100, 1150 and 1200 ° C., only the peak of β-TCP was detected as the composition of the molded product after firing (Fig. 5-a). In the sample having a firing temperature of 1250 ° C., a β-TCP peak was mainly detected as the composition of the molded product after firing, and a slight α-TCP peak was also detected (FIG. 5-b). In the sample having a firing temperature of 1500 ° C., no β-TCP peak was confirmed, and only the α-TCP peak was detected (Fig. 5-c).
[骨再生試験結果]
成形体の焼成処理温度が高くなるほど、粒子の数が減少し、粒子径が大きくなり、表面が滑らかになっていることがわかる(図3-b)。各処理温度のサンプルを生体内に埋入したところ、1100TCPでは炎症細胞の浸潤などの異物反応が確認された。組成中にβ-TCPのみが確認された条件のうち、もっとも高温で処理された1200TCPでは炎症反応は減少し、新しい骨細胞が確認された(図4)。組成中にα−TCPが確認された1250TCPでは、再び炎症反応が確認された。1500TCPは4週間の間に埋入されたサンプルが溶解していた(図4)。したがって、1200℃で焼成して得られる成形体を用いることが、最も好適な実施態様であることがわかる。
[Bone regeneration test results]
It can be seen that as the firing treatment temperature of the molded product increases, the number of particles decreases, the particle size increases, and the surface becomes smooth (FIG. 3-b). When a sample at each treatment temperature was implanted in the living body, a foreign body reaction such as infiltration of inflammatory cells was confirmed by 1100 TCP. Among the conditions in which only β-TCP was confirmed in the composition, 1200 TCP treated at the highest temperature reduced the inflammatory response and confirmed new bone cells (Fig. 4). In 1250 TCP, in which α-TCP was confirmed in the composition, an inflammatory reaction was confirmed again. In 1500 TCP, the embedded sample was dissolved during 4 weeks (Fig. 4). Therefore, it can be seen that the most preferable embodiment is to use a molded product obtained by firing at 1200 ° C.
Claims (7)
前記部材は一面から他面まで垂直方向に連通する複数の連通孔が設けられており、前記連通孔の孔径が100〜600μmであり、
硬膜と骨膜とが最短距離で結ばれる仮想軸と前記連通孔の向きとが略平行となるように骨欠損部に前記部材を配置することにより前記連通孔の全てに骨組織が形成されて頭蓋骨を再建するために用いられることを特徴とする、頭蓋骨接合部材。 A skull junction member consisting of β-tricalcium phosphate.
The member is provided with a plurality of communication holes that vertically communicate from one surface to the other, and the hole diameter of the communication holes is 100 to 600 μm.
By arranging the member in the bone defect portion so that the virtual axis connecting the dura mater and the periosteum at the shortest distance and the direction of the communication hole are substantially parallel , bone tissue is formed in all of the communication holes. A skull joint member, characterized in that it is used to reconstruct a skull.
The method for producing a skull joining member according to claim 6, wherein after the firing step, a medium containing 0.1 to 1000 μg / mL of BMP is impregnated with the member.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016228643A JP6803067B2 (en) | 2016-11-25 | 2016-11-25 | Skull joint member |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016228643A JP6803067B2 (en) | 2016-11-25 | 2016-11-25 | Skull joint member |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018082963A JP2018082963A (en) | 2018-05-31 |
| JP6803067B2 true JP6803067B2 (en) | 2020-12-23 |
Family
ID=62237864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016228643A Active JP6803067B2 (en) | 2016-11-25 | 2016-11-25 | Skull joint member |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6803067B2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3061732B2 (en) * | 1993-09-13 | 2000-07-10 | 旭光学工業株式会社 | Ceramics functional material providing a place for osteoinduction and bone formation, and method for producing the same |
| DE19940717A1 (en) * | 1999-08-26 | 2001-03-01 | Gerontocare Gmbh | Resorbable bone replacement and bone augmentation material |
-
2016
- 2016-11-25 JP JP2016228643A patent/JP6803067B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018082963A (en) | 2018-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1131075C (en) | Method for preparing an implantable composite material, resulting material, implant including said material, and kit therefor | |
| US11357886B2 (en) | Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them | |
| KR20150015532A (en) | Tissue repair devices and scaffolds | |
| JPH0156777B2 (en) | ||
| US20180000987A1 (en) | Porous bone substitutes and method of preparing the same | |
| EP2130557A1 (en) | Bone Graft Substitute | |
| JP5578499B2 (en) | Calcium phosphate / biodegradable polymer hybrid material, its production method and implant using the hybrid material | |
| JP2007501054A (en) | Calcium phosphate cement medical implant manufacturing method and medical implant | |
| JP6803067B2 (en) | Skull joint member | |
| KR20110129007A (en) | Granular porous bone graft material and its manufacturing method | |
| Elghazel et al. | TCP-fluorapatite composite scaffolds: mechanical characterization and in vitro/in vivo testing | |
| KR102868648B1 (en) | Injection-type synthetic bone and method for synthesizing there of | |
| CA2994049C (en) | Large 3d porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them | |
| JP2006020930A (en) | Calcium phosphate bone filling material | |
| Junior et al. | Physical Characterization of Biphasic Materials With Different Granulation Sizes and Their Influence on Bone Repair and Inflammation in Rat Calvaria | |
| KR101294963B1 (en) | Porous scaffold prepared by using plant template and manufacturing method thereof | |
| HK1256767A1 (en) | Large 3d porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them | |
| HK1256767B (en) | Large 3d porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them | |
| JP2003320014A (en) | Structure body made of biocompatible material impregnated with fine bone dust, and method of manufacturing the same | |
| ITUB20152962A1 (en) | Large porous 3D scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures | |
| ITUB20152939A1 (en) | Process to produce large porous 3D scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures? | |
| DE202016103296U1 (en) | Bone substitute made of zirconia ceramic | |
| JP2005329005A (en) | Biomaterial | |
| DE102016110622A1 (en) | Bone substitute made of zirconia ceramic | |
| KR20160134091A (en) | MULTIPOROUS HYDROXYAPATITE-TRICALCIUM PHOSPHATE CERAMIC COMPOSITES(biphasic calcium phosphate: BCP) USING AMMONIUM HYDROGEN CARBONATE AS SUPPORT BODY AND METHOD FOR MANUFACTURING THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190805 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200629 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200714 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200911 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201117 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201120 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6803067 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |